We’re honored to introduce a timely and thought-provoking conversation with Dr. Xavier Luria, the recently appointed Chair of the GMDP Academy Board. Dr. Luria brings decades of leadership in regulatory science, having served in key roles at the European Medicines Agency and as a respected global consultant and academic.
In this exclusive interview, Dr. Luria reflects on the Academy’s evolution, the critical role of international collaboration, and how regulatory science must adapt in the age of AI, personalized medicine, and real-world data. He shares his vision for fostering innovation, inclusivity, and lifelong learning across the global professional community.
Whether you’re a regulatory professional, healthcare leader, or student of medicines development, this conversation offers powerful insight into the future of the field—and how the Academy is leading that charge. View the complete interview below.
- The material in these reviews is from various public open access sources, meant for educational and informational purposes only
- Any personal opinions expressed are those of only the author(s) and are not intended to represent the position of any organization(s)
- No official support by any organization(s) has been provided or should be inferred
